Andere talen Invion Limited

Aandelen

IVX

AU000000IVX4

Beurs gesloten - Australian S.E. Andere beurzen 08:10:12 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,005 ^AUD	-16,67%		-16,67%	0,00%

05/03	Invion's antikankermedicijn boekt positieve preklinische testresultaten	MT
27/02	Invion Limited rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	05/03
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Invion Signs Collaboration Agreement with Dr. I&B Co for HPV Treatment; Shares Up 25%	23/02
Invion Nears Clinical Trial of Cancer Photodynamic Therapy with Drug Substance Production	21/11
Invion Grants RMW Cho Group Right to Distribute Cancer Treatment Products in South Korea	26-09-23
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Invion Launches New Interactive Investor Hub	11-04-23
Invion Limited agreed to acquire Next Generation Photodynamic Therapy of RMW Cho Group Limited.	06-04-23
Invion Limited Reports Earnings Results for the Half Year Ended December 31, 2022	22-02-23
Invion Expanding Photosoft Technology Rights to US, Canada, Hong Kong	08-02-23
Invion Limited Announces Vitro Test Results on Photosoft	26-10-22
Invion Limited Announces the Positive Screening Results from in Vitro Studies of PhotosoftTM on the Inhibition of the Dengue Virus	24-10-22
Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer	15-09-22
Invion Limited Announces INV043 Effective Against Anal Cancer Squamous Cell Carcinomas in Vitro	15-09-22
Invion Limited Announces PhotosoftTM Shows Activity Against Zika Virus in Preliminary Assays	08-09-22
Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2022	18-08-22
Invion : Activities Report and Appendix 4C	21-07-22
Invion : Notification regarding unquoted securities - IVX	20-06-22
Invion's Cancer Treatment Patent Application Published	09-06-22
Invion Limited Announces International Patent to Extend IP Protection for Photosoft	08-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Invion Limited

Aandelen

IVX

AU000000IVX4

Andere talen

Filters